The aim of the study is to obtain an understanding of relevant parameters affecting the performance of ostomy products.
72 subjects will be included. Each subject will attend 3 visits at the clinic/hospital or at the subjects home depending on the final site set-up. Each subject will be enrolled for 14 weeks in total for the entire investigation. Coloplast will provide SenSura Mio Convex Soft for all subjects via the investigator. Based on the subjects' usual changing pattern, the investigator will provide the subjects with enough products for the whole test period. The subject will answer questions regarding the tested products by filling out the subject part in the eCRF daily. The subject will answer questions using an electronic device and use the device to take pictures of the peristomal skin and used products at each product change. The Investigator fills out the investigator part of the eCRF at each visit. The subjects must complete the general questions at the end of each test period before their second and third visit at the Clinic/hospital or at home to avoid influence by the investigator. The use of accessories will be noted in the eCRF. Samples of biological material will not be taken or used in this investigation. Patient files from own physician will not be used for subjects recruited via a Coloplast's database. The investigators may use patient files for subjects recruited via hospital sites/ostomy clinics to identifying relevant subjects and/or to verify baseline information, concomitant medication or adverse events. To be able to fulfil the objectives, the investigation must include both ileostomists and colostomists.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
74
SenSura Mio Convex Soft is a CE marked ostomy product manufactured by Coloplast
University of Chicago Medicine
Chicago, Illinois, United States
Prism research center
Saint Paul, Minnesota, United States
QPS Netherlands
Groningen, Netherlands
Helse Nordbyen
Larvik, Norway
Leakage Under the Baseplate (cm^2)
The leakage area was measured using photos of used baseplates. A computer program was used to measure the leakage area.
Time frame: 14 weeks (2 weeks baseline + 12 weeks intervention)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Synexus Midlands
Birmingham, United Kingdom
Pilgrim Hospital
Boston, United Kingdom
Cheltenham General Hospital
Cheltenham, United Kingdom
Kettering General hospital
Kettering, United Kingdom
Lincon Country hospital
Lincoln, United Kingdom